IDO1 methylation by EZH2 confers resistance to its targeted therapy in colorectal cancer through tryptophan-kynurenine metabolic rewiring. (linkinghub.elsevier.com)

Authors: Tang Y … Xue L Journal: Cell Reports Published: 2026-11-05 DOI: https://doi.org/10.1016/j.celrep.2026.118237